Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Cillo, Umberto ^a   Vitale, Alessandro ^a   Dupuis, Davide ^a   Corso, Stefano ^a   Neri, Daniele ^a   D'Amico, Francesco ^a   Gringeri, Enrico ^a   Farinati, Fabio ^a   Vincenzi, Valter ^b   Zanus, Giacomo ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b SAN MARTINO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; ASCITES; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEASIBILITY STUDY; FEMALE; HEPATITIS C; HUMAN; LAPAROSCOPIC SURGERY; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; MORBIDITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR ABLATION;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COHORT STUDIES; ETHANOL; FEMALE; HEPATITIS C; HUMANS; HYPERTENSION, PORTAL; LAPAROSCOPY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MICROWAVES; MIDDLE AGED; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84874294129     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057249     Document Type: Article

References (40)

1. Bruix J, Sherman M, (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236 doi:10.1002/hep.20933.
2. Bruix J, Sherman M, (2011) Management of hepatocellular carcinoma: An update. Hepatology 53: 1020-1022 doi:10.1002/hep.24199.
3. Llovet JM, Bruix J, (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48: S20-S37 doi:10.1016/j.jhep.2008.01.022.
4. Mirici-Cappa F, Gramenzi A, Santi V, Zambruni A, Di Micoli A, et al. (2010) Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 59: 387-396 doi:10.1136/gut.2009.194217.
5. Ho M-C, Huang G-T, Tsang Y-M, Lee P-H, Chen D-S, et al. (2009) Liver Resection Improves the Survival of Patients with Multiple Hepatocellular Carcinomas. Ann Surg Oncol 16: 848-855 doi:10.1245/s10434-008-0282-7.
6. Ramsey D, Kernagis L, Soulen M, Geschwind J, (2002) Chemoembolization of Hepatocellular Carcinoma. J Vasc Interv Radiol 13: S211-S221 doi:10.1016/S1051-0443(07)61789-8.
7. Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, et al. (2011) Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology 53: 1580-1589 doi:10.1002/hep.24246.
8. Raoul J-L, Sangro B, Forner A, Mazzaferro V, Piscaglia F, et al. (2011) Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 37: 212-220 doi:10.1016/j.ctrv.2010.07.006.
9. Kurokohchi K, Watanabe S, Yoneyama H, Deguchi A, Masaki T, et al. (2008) A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma. World J Gastroenterol 14: 2037-2043.
10. Santambrogio R, Podda M, Zuin M, Bertolini E, Bruno S, et al. (2003) Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis. Surg Endosc 17: 1826-1832 doi:10.1007/s00464-002-8960-1.
11. Berber E, Siperstein AE, (2007) Perioperative outcome after laparoscopic radiofrequency ablation of liver tumors: an analysis of 521 cases. Surg Endosc 21: 613-618 doi:10.1007/s00464-006-9139-y.
12. Buell JF, Thomas MT, Rudich S, Marvin M, Nagubandi R, et al. (2008) Experience With More Than 500 Minimally Invasive Hepatic Procedures. Ann Surg 248: 475-486 doi:10.1097/SLA.0b013e318185e647.
13. Belli G, D'Agostino A, Fantini C, Cioffi L, Belli A, et al. (2007) Laparoscopic Radiofrequency Ablation Combined With Laparoscopic Liver Resection for More Than One HCC on Cirrhosis. Surg Laparo Endo Per 17: 331-334 doi:10.1097/SLE.0b013e31806d9c65.
14. Minami Y, Kudo M, (2010) Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol 2: 417-424 doi:10.4329/wjr.v2.i11.417.
15. Tanaka S, Shimada M, Shirabe K, Taketomi A, Maehara S, et al. (2009) Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach. Hepato-Gastroenterol 56: 1169-1173.
16. Cillo U, Vitale A, Grigoletto F, Gringeri E, D'Amico F, et al. (2007) Intention-to-Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria. Am J Transplant 7: 972-981 doi:10.1111/j.1600-6143.2006.01719.x.
17. Vitale A, D'Amico F, Frigo AC, Grigoletto F, Brolese A, et al. (2010) Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. Ann Surg Oncol 17: 2290-2302 doi:10.1245/s10434-010-0993-4.
18. The Cancer of the Liver Italian Program (CLIP) Investigators (2000) Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31: 840-845 doi:10.1053/he.2000.5628.
19. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, Lertmaharit S, Hanvivatvong O, et al. (2000) Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 31: 302-308.
20. Asahina Y, Nakanishi H, Izumi N, (2009) Laparoscopic radiofrequency ablation for hepatocellular carcinoma. Dig Endosc 21: 67-72 doi:10.1111/j.1443-1661.2009.00844.x.
21. Santambrogio R, Opocher E, Zuin M, Selmi C, Bertolini E, et al. (2009) Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis. Ann Surg Oncol 16: 3289-3298 doi:10.1245/s10434-009-0678-z.
22. Ballem N, Berber E, Pitt T, Siperstein A, (2008) Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up. HPB (Oxford) 10: 315-320 doi:10.1080/13651820802247102.
23. Berber E, Siperstein A, (2008) Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol 15: 2757-2764 doi:10.1245/s10434-008-0043-7.
24. Hsieh C-B, Chang H-M, Chen T-W, Chen C-J, Chan D-C, et al. (2004) Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma. World J Gastroenterol 10: 505-508.
25. Tesche LJ, Newton KN, Unger J, Semelka RC, Gerber DA, (2010) Efficacy and Tolerability of Laparoscopic-assisted Radiofrequency Ablation of Hepatocellular Carcinoma in Patients Above 60 Years of Age. Surg Laparo Endo Per 20: 404-409 doi:10.1097/SLE.0b013e3181fd619b.
26. Casaccia M, Andorno E, Nardi I, Troilo B, Barabino G, et al. (2008) Laparoscopic US-Guided Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Liver Cirrhosis: Feasibility and Clinical Outcome. J Laparoendosc Adv A 18: 797-801 doi:10.1089/lap.2008.0039.
27. Seki S, Sakaguchi H, Iwai S, Kadoya H, Kabayashi S, et al. (2005) Five-year Survival of Patients with Hepatocellular Carcinoma Treated with Laparoscopic Microwave Coagulation Therapy. Endoscopy 37: 1220-1225 doi:10.1055/s-2005-921035.
28. Kawamoto C, Ido K, Isoda N, Hozumi M, Nagamine N, et al. (2005) Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation. Cancer 103: 985-993 doi:10.1002/cncr.20880.
29. Lam VW-T, Ng KK-C, Chok KS-H, Cheung T-T, Yuen J, et al. (2008) Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma. J Am Coll Surgeons 207: 20-29 doi:10.1016/j.jamcollsurg.2008.01.020.
30. Cassera MA, Potter KW, Ujiki MB, Swanström LL, Hansen PD, (2011) Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs. Surg Endosc 25: 1088-1095 doi:10.1007/s00464-010-1322-5.
31. Vitale A, Ramirez Morales R, Zanus G, Farinati F, Burra P, et al. (2011) Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Lancet Oncol 12: 654-662 doi:10.1016/S1470-2045(11)70144-9.
32. Bruix J, Llovet JM, (2009) Major achievements in hepatocellular carcinoma. Lancet 373: 614-616 doi:10.1016/S0140-6736(09)60381-0.
33. Lo C-M, Ngan H, Tso W-K, Liu C-L, Lam C-M, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35: 1164-1171 doi:10.1053/jhep.2002.33156.
34. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. (1996) Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis. N Engl J Med 334: 693-700 doi:10.1056/NEJM199603143341104.
35. Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, et al. (2009) An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 15: 859-868 doi:10.1002/lt.21778.
36. Volk ML, Vijan S, Marrero JA, (2008) A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria. Am J Transplant 8: 839-846 doi:10.1111/j.1600-6143.2007.02138.x.
37. Belghiti J, (2009) Resection and liver transplantation for HCC. J Gastroenterol 44: 132-135 doi:10.1007/s00535-008-2250-1.
38. N'Kontchou G, Aout M, Laurent A, Nahon P, Ganne-Carrié N, et al. (2012) Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis. J Hepatol 56: 160-166 doi:10.1016/j.jhep.2011.03.026.
39. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, et al. (2007) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47: 82-89 doi:10.1002/hep.21933.
40. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, et al. (2008) Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma. Gastroenterology 134: 1908-1916 doi:10.1053/j.gastro.2008.02.091.